Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review

doi:10.12998/wjcc.v13.i27.105415

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (304)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

165

Figures (1-2)

Tables (1-1)

Sum=217

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=54

Publishing Process of This Article

Item

Count

Browse

Download

Sum=25

Sep 26, 2025 (publication date) through Aug 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Sep 26, 2025; 13(27): 105415
Published online Sep 26, 2025. doi: 10.12998/wjcc.v13.i27.105415

Full Size Figure Download Figure

Figure 1 The inactive lactone prodrug of monacolin K (lovastatin) is on the left, and its lipid-lowering active metabolite, monacolin K hydroxy acid, is on the right.

Citation: English K. Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review. World J Clin Cases 2025; 13(27): 105415
URL: https://www.wjgnet.com/2307-8960/full/v13/i27/105415.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i27.105415